Back to search

Article

Low Expression of Iron–Sulfur Cluster Binding Protein RFESD Predicts Adverse Clinic Outcomes in Acute Myeloid Leukemia

2026-07-05

Abstract excerpt

<title>Abstract</title> <p>Acute myeloid leukemia (AML) is a devastating hematopoietic malignancy with high heterogeneity and poor outcomes. In this study, we searched for the new biomarker to promote the efficacy of diagnosis, therapy and prognosis of AML by transcriptome and clinical information from the Cancer Genome Atlas (TCGA) database, Gene Expression Omnibus (GEO) datasets, and Genotype-Tissue Expression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0da77f18-18af-5aec-a199-7c8d15d74d11
DOI
10.21203/rs.3.rs-10224596/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low Expression of Iron–Sulfur Cluster Binding Protein RFESD Predicts Adverse Clinic Outcomes in Acute Myeloid LeukemiaDOI 10.21203/rs.3.rs-10224596/v1
Select a neighboring publication to make it the new centre.